Grüneberg R N, Smellie J M, Leakey A, Atkin W S
Br Med J. 1976 Jul 24;2(6029):206-8. doi: 10.1136/bmj.2.6029.206.
The bacteriological consequences of giving long-term low-dose co-trimoxazole to children to prevent reinfection of the urinary tract were studied. Only six "break-through" infections occurred during 2637 child-months of prophylaxis. The children complied well with treatment. During prophylaxis the number of rectal coliform bacilli recovered was greatly and rapidly reduced, but at least 70% of the surviving coliform organisms remained sensitive to the two components of co-trimoxazole. Changes in sensitivity pattern were evident within a month of starting treatment and the proportion of rectal organisms resistant to sulphonamide or trimethoprim did not increase with time. After stopping co-trimoxazole prophylaxis the number of rectal organisms recoverable returned rapidly to normal, as did their sensitivities to trimethoprim and sulphonamide. Further episodes of urinary tract infection developing after prophylaxis was stopped were caused by organisms sensitive to a wide range of antimicrobial agents, including trimethoprim.
研究了长期给儿童服用低剂量复方新诺明以预防尿路感染再感染的细菌学后果。在2637个儿童月的预防期内,仅发生了6次“突破性”感染。儿童对治疗的依从性良好。在预防期间,回收的直肠大肠埃希菌数量大幅迅速减少,但至少70%存活的大肠埃希菌对复方新诺明的两种成分仍敏感。在开始治疗后的一个月内,敏感性模式就有明显变化,对磺胺类药物或甲氧苄啶耐药的直肠菌比例并未随时间增加。停止复方新诺明预防后,可回收的直肠菌数量迅速恢复正常,它们对甲氧苄啶和磺胺类药物的敏感性也恢复正常。停止预防后发生的进一步尿路感染发作是由对包括甲氧苄啶在内的多种抗菌药物敏感的细菌引起的。